Cellosaurus logo
expasy logo

Cellosaurus YCU-H891 (CVCL_8017)

[Text version]
Cell line name YCU-H891
Synonyms YCU H891
Accession CVCL_8017
Resource Identification Initiative To cite this cell line use: YCU-H891 (RRID:CVCL_8017)
Comments Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=26780976; PubMed=26781072). Originally thought to originate from an hypopharyngeal squamous cell carcinoma.
Population: African American.
Doubling time: 11.08 hours (PubMed=21362583).
Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
Miscellaneous: HLA typing and STR profile from personal communication of Sano D.
Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
HLA typing Source: Direct_author_submission
Class I
HLA-AA*68:02
Disease Human papillomavirus-related cervical adenocarcinoma (NCIt: C27677)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_0030 (HeLa)
Sex of cell Female
Age at sampling 30Y6M
Category Cancer cell line
STR profile Source(s): Direct_author_submission

Markers:
AmelogeninX
CSF1PO9,10
D3S135815,18
D5S81811,12
D7S8208,12
D8S117912,13
D13S31712,13.3
D16S5399,10
D18S5116
D21S1127,28
FGA21
Penta D8,15
Penta E7,17
TH017
TPOX8,12
vWA16,18

Run an STR similarity search on this cell line
Publications

PubMed=18097577; DOI=10.3892/or.19.1.65
Taguchi T., Tsukuda M., Imagawa-Ishiguro Y., Kato Y., Sano D.
Involvement of EGFR in the response of squamous cell carcinoma of the head and neck cell lines to gefitinib.
Oncol. Rep. 19:65-71(2008)

PubMed=21362583; DOI=10.1016/j.anl.2011.01.018
Sakakibara A., Tsukuda M., Kondo N., Ishiguro Y., Kimura M., Fujita K., Takahashi H., Matsuda H.
Examination of the optimal condition on the in vitro sensitivity to telomelysin in head and neck cancer cell lines.
Auris Nasus Larynx 38:589-599(2011)

PubMed=21631644; DOI=10.1111/j.1349-7006.2011.01999.x
Kondo N., Tsukuda M., Taguchi T., Nakazaki K., Sakakibara A., Takahashi H., Toth G., Nishimura G.
Gene status of head and neck squamous cell carcinoma cell lines and cetuximab-mediated biological activities.
Cancer Sci. 102:1717-1723(2011)

PubMed=26780976; DOI=10.3892/or.2016.4573
Sano D., Matsuda H., Ishiguro Y., Nishimura G., Kawakami M., Tsukuda M.
Corrigendum: Antitumor effects of IDN5109 on head and neck squamous cell carcinoma.
Oncol. Rep. 35:2494-2494(2016)

PubMed=26781072; DOI=10.3892/or.2016.4574
Sano D., Kawakami M., Fujita K., Kimura M., Yamashita Y., Ishiguro Y., Nishimura G., Matsuda H., Tsukuda M.
Corrigendum: Antitumor effects of ZD6474 on head and neck squamous cell carcinoma.
Oncol. Rep. 35:2495-2495(2016)

Cross-references
Encyclopedic resources Wikidata; Q54995348
Polymorphism and mutation databases Cosmic; 1136975
Cosmic; 1556186
Entry history
Entry creation04-Apr-2012
Last entry update05-Oct-2023
Version number18